CSF2 and neoplasm: Recent studies showed that knockdown of GM-CSF in tumor cells or blockade of GM-CSF with antibody reduces expansion of MDSCs, delays tumor progression, and enhances the efficiency of PD-L1 antibody 44, 45, while the underlying mechanism remains vague.